Advisor Group Holdings, Inc. Hcw Biologics Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,010 shares of HCWB stock, worth $6,716. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,010Holding current value
$6,716% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HCWB
# of Institutions
16Shares Held
1.16MCall Options Held
0Put Options Held
0-
Avantax Planning Partners, Inc.280KShares$1.86 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA243KShares$1.62 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA237KShares$1.58 Million0.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$877,7330.01% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL75.1KShares$499,5210.01% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $238M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...